Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case Report

Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case Report

Background: Mucosal melanomas including melanomas of the urogenital tract represent a rare type of melanoma characterized by low mutational burden and poor prognosis. Immune checkpoint inhibition has so far only been assessed in a limited number of mucosal melanoma patients and, in contrast to respo...

Full description

Bibliographic Details
Main Authors: Anne Fröhlich, Friederike Hoffmann, Dennis Niebel, Eva Egger, Guido M. Kukuk, Marieta Toma, Judith Sirokay, Thomas Bieber, Jennifer Landsberg
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Oncology
Subjects:
immune checkpoint blockade
intralesional treatment
mucosal melanoma
primary resistance
talimogene laherparepvec
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00611/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00611/full

Similar Items